# corporate%20governance
Latest news and articles about corporate%20governance
Total: 47 articles found
China’s Exchanges Loosen Re‑financing Rules to Back Tech R&D — with New Guardrails
China’s three main stock exchanges have eased refinancing rules to help R&D‑intensive and unprofitable science‑and‑technology firms raise capital more quickly, extended a ‘light‑asset, high‑R&D’ standard to main boards, and streamlined procedures while tightening oversight to prevent misuse. The package is calibrated to sustain long‑term innovation funding while guarding against speculative or control‑seeking abuses.
Family Control, Faulty Toilets and Forced Make‑ups: How Arrow Home’s Governance and ESG Gaps Are Hitting Its Business
Arrow Home, a major Chinese sanitaryware maker, faces mounting reputational and financial strain after consumer complaints, alleged labor‑rights violations and a family‑dominated governance structure exposed weaknesses in its ESG performance. Despite middling Wind ESG ratings and a recent publicity partnership, falling revenues and a dividend plan that exceeds net profit raise questions about the company's long‑term resilience.
Konka's Fall: China’s Once-Dominant TV Maker Posts Billions in Losses and Faces Delisting Risk
Konka, once a leader in China’s television market, warned of a RMB 12.58–15.57 billion net loss for 2025 and faces a likely negative net-asset position and possible delisting. Years of shrinking TV sales, sprawling diversification, mounting impairments and governance lapses have culminated in a balance-sheet crisis that China Resources has begun to address but cannot resolve alone.
China’s Aier Empire Exposed: Psychiatric Hospital Fraud Lifts the Veil on a Hidden Medical Network
Allegations of systematic medical‑insurance fraud at several psychiatric hospitals in Hubei have revealed links to Aier Medical Investment, the non‑listed vehicle controlled by Chen Bang, founder of listed Aier Eye. The case spotlights how opaque ownership layers can shield high‑risk healthcare businesses and raises the prospect of intensified regulatory and market scrutiny across China’s private medical sector.
China’s E‑Paper Champion Faces Regulator’s Scissors: Investigation and Asset Freezes Threaten Qingyue’s Survival
China’s securities regulator has opened a formal investigation into Qingyue Technology over alleged false financial reporting and has frozen key securities and fundraising bank accounts. The probe follows prior warnings about misuse of raised funds, undisclosed related‑party deals and a disputed export‑tax rebate, and raises the spectre of forced delisting amid weak industry conditions and strained company finances.
China’s Securities Regulator Opens Probe Into Listed Firm Yahui Long Over Disclosure Irregularities
Yahui Long said it received a formal CSRC filing notice on 6 February 2026 alleging suspected information-disclosure violations, triggering an official investigation. The move fits a broader regulatory tightening by Chinese authorities aimed at improving market governance and could provoke short-term share-price volatility and closer scrutiny of the company.
Food‑safety warning clouds Ban U hotpot’s Hong Kong IPO push
Nanjing regulators detected excessive bifenthrin residue on oranges served at a Ban U hotpot branch, a finding that collides with the chain's quiet‑period preparations for a Hong Kong IPO. The incident highlights how food‑safety lapses and governance questions can complicate capital‑markets plans for consumer brands in China.
A Fall from Grace: How a Bitter Fight Over Huiyuan Juice Has Left Jiang Zhaobai’s Listed Empire Hanging On
A violent ownership dispute over Beijing Huiyuan has derailed a planned asset injection into Guozhong Water and triggered large impairments that put the company at risk of *ST designation and possible delisting. The turmoil exposes broader weaknesses in the Pengxin group controlled by Jiang Zhaobai — from disputed mining acquisitions and unmet performance guarantees to heavy share pledges and governance lapses — and raises questions about recoverability for creditors and minority shareholders.
Bestore’s Balance‑Sheet Blind Spot: How an Overleveraged Controlling Shareholder Deepens the Snack Chain’s Turnaround Challenge
Bestore disclosed that its controlling shareholder, Ningbo Hanyi, faces court execution over about RMB 280 million of overdue trust debt, putting a large block of pledged shares at risk. The company is also reporting a sizable 2025 loss after continued store closures and margin pressure, while prior plans to bring in strategic investors failed to materialize.
Executive Exodus and Mounting Losses Leave Regional Baijiu Maker TianYouDe on the Brink
TianYouDe, a regional Qinghai baijiu producer, faces a management exodus and a sharp earnings collapse, with 2025 net profit forecast to slump by up to 90% while inventory sits at five years' worth of sales. Operational inefficiency, failed overseas expansion and weak distributor confidence have left the company exposed as national brands encroach and consumer demand cools.
China’s ‘First Grain Stock’ Hit with Regulatory Rebuke After Subsidiary’s Fake Trades Inflate Revenue
Hunan regulators found that a Jinjian Rice Industry subsidiary used circular, empty trades from 2020–2022 to improperly inflate revenue by over RMB 586 million. The company was ordered to correct disclosures and four former executives received warning letters and were added to the securities‑market integrity file. Jinjian has since divested trading units and repositioned toward grain and oil processing to reduce trading exposure.
From ‘TV King’ to Balance‑Sheet Crisis: Konka Warns of RMB125–156bn Annual Loss, Fuels Delisting Fears
Konka, a once‑dominant Chinese television maker, has warned of an RMB12.6–15.6 billion full‑year loss for 2025 driven by large fourth‑quarter impairment charges. The forecast has pushed the company toward negative net assets, raised delisting risks, and intensified governance probes following a recent state‑linked takeover.